Protective Effect of Ganoderma (Lingzhi) on Cardiovascular System

Area of Science:

• Cardiology
• Pharmacology
• Integrative Medicine

Background:

• Cardiovascular diseases (CVDs) are a leading cause of global mortality, responsible for 17.9 million deaths annually.
• Ganoderma lucidum (G. lucidum, Lingzhi) is a medicinal mushroom with demonstrated effects on metabolic health.
• Existing research suggests G. lucidum may influence key cardiovascular risk factors and offer cardioprotection.

Purpose of the Study:

• To summarize the preventive and therapeutic effects of G. lucidum on cardiovascular diseases.
• To explore the potential clinical applications of G. lucidum in managing heart conditions.

Main Methods:

• Review of existing scientific literature on G. lucidum and cardiovascular health.
• Analysis of studies investigating G. lucidum's impact on metabolic markers (LDL, HDL, TC, blood pressure, oxidative damage).
• Examination of G. lucidum's efficacy in various animal models of cardiovascular disease (e.g., diabetic, hypertrophy, toxicity, constriction models).

Main Results:

• G. lucidum influences metabolic markers, including reductions in LDL, total cholesterol, and blood pressure, alongside improvements in HDL and oxidative damage.
• G. lucidum demonstrated protective effects against heart damage in multiple disease models, such as streptozotocin-induced diabetes, high-fat-diet-induced diabetes, myocardial hypertrophy, and acute heart toxicity.
• Evidence suggests G. lucidum possesses both preventive and therapeutic potential for cardiovascular conditions.

Conclusions:

• Ganoderma lucidum shows promise in reducing cardiovascular disease risk through metabolic modulation and direct cardioprotection.
• Further clinical research is warranted to establish the efficacy and optimal use of G. lucidum in human cardiovascular health.
• G. lucidum represents a potential complementary therapy for cardiovascular disease management.